Columbia University Irving Medical Center Signs Academic & Research Agreement with top Chilean Institutions

July 24, 2018

In early November, Columbia University Irving Medical Center (CUMC) will co-sponsor a major symposium in Santiago entitled "Immunodeficiencies and Immune Dysregulation: from Translational Immunology to personalized Medicine". This is the first of many activities to be carried out in the framework of an academic and research collaboration agreement signed in July by CUMC, represented by Dr. Lawrence Stanberry, Associate Dean for International Programs at the University’s Vagelos College of Physicians and Surgeons, with Chile’s Universidad del Desarrollo (UDD), the School of Medicine Clínica Alemana-UDD, and the Institute of Sciences and Innovation in Medicine (ICIM).

The agreement includes joint-research and educational activities as well as possible student and practitioner exchanges.

The November event, which is also being co-sponsored by the Santiago Center, will include the participation of Columbia University’s Dr. Jordan S. Orange, Chair of Pediatrics; Dr. Wendy K. Chung, clinical and molecular geneticist and the Kennedy Family Professor of Pediatrics and Medicine; and Lawrence Stanberry. Other prominent international immunologists and geneticists that will take part in this meeting include Dr. James R. Lupskifrom Baylor College of Medicine; Isabelle Meytz from Belgium; Joshua Milner, from theNational Institute of Allergies and Infectious Diseases; experts from the local institutions hosting the gathering (the Translational Immunology Program at ICIM and Clínica Alemana-Universidad del Desarrollo); and representatives from Chile´s Hospital Luis Calvo Mackenna.

Topics to be discussed include precision medicine in primary immunodeficiencies; gene discovery in primary and immune dysregulation syndromes including allergies; autoimmune diseases focusing on exome sequencing and interpretation; and state of the art strategies for diagnosis and targeted treatments.

While in Chile, Dr. Stanberry held a series of meetings with UDD authorities and faculty members, ICIM researchers, and practitioners at Clínica Alemana and Padre Hurtado Hospital, the main clinical training centers of UDD’s School of Medicine.


Photo: Dr. Cecilia Poli, Director of the Translational Immunology program at theInstitute of Sciences and Innovation in Medicine (ICIM); Dr. Lawrence Stanberry, Associate Dean for International Programs at Columbia  University’s Vagelos College of Physicians and Surgeons; Dr. Ricardo Ronco, Dean at School of Medicine Clínica Alemana-UDD; Dr. Denise Saint Jean, Director of Research and PhDs at UDD; Daniel Contesse, ViceProvost of Innovation and Development at UDD; Dr. Pablo Vial, Director of ICIM; Nancy Perez, Director of Knowledge Management and Technological Innovation at UDD.